Cargando…
Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327822/ https://www.ncbi.nlm.nih.gov/pubmed/32637660 http://dx.doi.org/10.1016/j.ctro.2020.06.001 |
_version_ | 1783552623620653056 |
---|---|
author | Slevin, Finbar Rodda, Sree Lakshmi Bownes, Peter Murray, Louise Bottomley, David Melody, Clare Adiotomre, Ese Al-Qaisieh, Bashar Dugdale, Emma Hulson, Oliver Mason, Joshua Smith, Jonathan Henry, Ann M. |
author_facet | Slevin, Finbar Rodda, Sree Lakshmi Bownes, Peter Murray, Louise Bottomley, David Melody, Clare Adiotomre, Ese Al-Qaisieh, Bashar Dugdale, Emma Hulson, Oliver Mason, Joshua Smith, Jonathan Henry, Ann M. |
author_sort | Slevin, Finbar |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7327822 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-73278222020-07-06 Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’ Slevin, Finbar Rodda, Sree Lakshmi Bownes, Peter Murray, Louise Bottomley, David Melody, Clare Adiotomre, Ese Al-Qaisieh, Bashar Dugdale, Emma Hulson, Oliver Mason, Joshua Smith, Jonathan Henry, Ann M. Clin Transl Radiat Oncol Article Elsevier 2020-06-10 /pmc/articles/PMC7327822/ /pubmed/32637660 http://dx.doi.org/10.1016/j.ctro.2020.06.001 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Slevin, Finbar Rodda, Sree Lakshmi Bownes, Peter Murray, Louise Bottomley, David Melody, Clare Adiotomre, Ese Al-Qaisieh, Bashar Dugdale, Emma Hulson, Oliver Mason, Joshua Smith, Jonathan Henry, Ann M. Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’ |
title | Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’ |
title_full | Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’ |
title_fullStr | Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’ |
title_full_unstemmed | Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’ |
title_short | Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’ |
title_sort | response to ‘unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’ |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327822/ https://www.ncbi.nlm.nih.gov/pubmed/32637660 http://dx.doi.org/10.1016/j.ctro.2020.06.001 |
work_keys_str_mv | AT slevinfinbar responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer AT roddasreelakshmi responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer AT bownespeter responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer AT murraylouise responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer AT bottomleydavid responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer AT melodyclare responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer AT adiotomreese responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer AT alqaisiehbashar responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer AT dugdaleemma responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer AT hulsonoliver responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer AT masonjoshua responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer AT smithjonathan responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer AT henryannm responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer |